Q&As
Thyroid
Hormone &
the Heart
[Q&As are placed in reverse chronological
order. In other words,
the latest Q&As come first. Earlier ones are further down the page.]
Endocrinology
Specialty's Exaggerated Warnings of Atrial
Fibrillation from TSH-Suppressive Doses of Thyroid Hormone
Pounding Heart after Starting Thyroid Hormone
August 1, 2011
Question: Why can't my heart tolerate
even low-dose thyroid hormone?
Note: We often received versions of this
question. The question is an extremely important one to answer. The reason
is that without proper answers, many people stop taking thyroid hormone and
likely suffer from the multiple harmful effects of too little thyroid
hormone regulation for prolonged times. To answer the question as
comprehensively as I can, we have posted it to my commentary section.
Please see the
heart page in that section to read my answers.
December 12, 2005

Question:
I'm a physician in North Carolina who uses your book
The Metabolic Treatment of
Fibromyalgia as a manual for treating my fibromyalgia patients. I
have now gotten many of these patients well by using doses of Armour or
Cytomel that my partners consider excessive. Their main concern is that the
doses I use may cause heart arrhythmias. A local endocrinologist recently
told one of my partners that sooner or later, I'm going to cause some of
these patients to have heart attacks. Because of the documentation you give
in the book, I'm comfortable using doses of thyroid hormone that are
obviously necessary for the patients to get well. I am curious, however,
what your current position is on the issue of thyroid treatment and
arrhythmias.
Dr. Lowe: Hardly a week passes that I
don't receive an email from a physician asking the same question you have.
My answer here is typical of what I send to them.
The major concern of our research and treatment team over the years has been
the safety of our patients. Out of that concern, I've given the subject of
thyroid hormone therapy and heart arrhythmias intense focus. I have studied
the entire research literature on the subject. In addition, our research and
treatment team may have run more ECGs (EKGs) and ordered more advanced
cardiac testing than any other clinic not specializing in cardiology.
We ran so many in years past that the results forced us to a conclusion:
it's the rarest exception when the ECG rhythm of a patient is of
concern. We've referred for cardiac consults the few patients who had
rhythms we were concerned about. Only once did a cardiologist advise that
the patient undergo cardiac rehab before beginning the use of thyroid
hormone. In every other case, the cardiologist said that thyroid hormone
therapy was safe for the patient. Some cardiologists said that the therapy
would most likely improve the patient's cardiac health.
My years of focus on this issue boil down to a few evidence-based
beliefs. Arrhythmias occur in some patients with hypothyroidism and thyroid
hormone resistance. They occur when the patients’ doctors deny them
thyroid hormone therapy, or when their doctors under-treat them with thyroid
hormone. We usually say these patients' arrhythmias result from
"hypothyroid heart."
Arrhythmias also occur in some patients with suppressed TSH levels. It's not
clear at all, however, that excessive thyroid hormone stimulation causes
these patients' arrhythmias. Unfortunately, the endocrinology specialty has
concluded from these studies that anyone taking TSH-suppressive doses of
thyroid hormone is likely to have heart arrhythmias. But this conclusion is
simply illogical, and it is self-contradictory for the specialty, as I
explain below.
Some researchers have reported an association of suppressed TSH levels
with heart arrhythmias. These studies, however, included only elderly,
sedentary individuals, some of whom were bedridden in nursing homes. None of
the researchers controlled for the influence of most of the important
heart-protective lifestyle factors. Because of this, the arrhythmias may
have been more strongly or wholly associated with unwholesome diet,
nutritional deficiencies, or low levels of cardiovascular fitness.
Also, the suppressed TSH levels of people in the studies weren't caused by
thyroid hormone therapy; researchers only found the low TSH levels upon
reviewing medical records of the people. This raises the possibility that
factors other than too much thyroid hormone were responsible for the
people's suppressed TSH levels.
For example, some of the people in the studies may have had pituitary
hypothyroidism. This is a condition in which the pituitary gland doesn't
produce a normal amount of TSH; as a result, patients have abnormally low
TSH levels. It’s important to note that these patients have deficiencies
of thyroid hormone, so thyroid hormone overstimulation couldn’t be the
cause of their arrhythmias. Other patients in the studies may have had some
degree of Graves' diseases. If so, then it's possible that their arrhythmias
were caused by some sort of cardiac cross-reaction with thyroid stimulation
antibodies.
For real clarity on this issue of arrhythmias, we must compare patients in
the studies I just mentioned (elderly, sedentary, often bedridden people) to
thyroid cancer patients. The comparison reveals an outrageous double
standard of therapy by the endocrinology specialty.
Nearly all thyroid cancer patients use TSH-suppressive dosages of thyroid
hormone. Through meta-analyses of many studies, researchers looked at the
heart condition of these patients—some of whom have suppressed their TSH
levels with thyroid hormone for decades. The researchers found that the
suppression has not compromised the health of the patients’ hearts.
Talking out of both sides of its collective mouth, the endocrinology
specialty continues to treat thyroid cancer patients with TSH-suppressive
dosages of thyroid hormone, while authoritatively warning hypothyroid
patients and other doctors that TSH-suppressive doses are likely to cause
arrhythmias and heart attacks. The specialty's self-contradicting
inconsistency is so glaring that it unveils conflicts of interest that
honorable people would be ashamed to be caught in.
From my study and clinical experience of this issue over the years, I've
derived a distinct impression that I justify in my forthcoming book Tyranny
of the TSH: The endocrinology specialty is unyielding in its
endorsement of T4-replacement, and this appears to me to be a commitment to
stabilize the financial market for the associated products of T4
replacement. Those products in the U.S. include Synthroid, and importantly,
they also include the TSH, free T4, and free T3 tests provided by labs.
It's my belief that the specialty uses the theoretical possibility of
cardiac arrhythmias as a scare tactic to intimidate other doctors into
ordering more-and-more of these lab tests, especially TSH tests. The
intimidation ensures the continuing huge sales of these tests. The sales
please the corporations that market the tests, and as a quid pro quo,
the corporations generously share their profits with the specialty. (As
others have noted, the sharing comes as huge financial grants, speaking
fees, sponsoring of speaking appearances, research funds, free drug samples
and patient literature, and logo gift items.)
The endocrinology specialty's obvious financial conflicts of interest are a
devastating blow to its credibility. In my mind, it has none left. I hold
suspect anything and everything that flows from the mouths or pens of the
specialty. And that certainly includes its scientifically-indefensible claim
that TSH-suppressive doses of thyroid hormone are likely to cause cardiac
arrhythmias.
For documentation, see:
Unrealistic
Worries About Thyroid Hormone Therapy and Heart Problems: The Source.
August 17, 2004

Question:
You explained somewhere on your website why hypothyroid
patients have a slow heart rate response to exercise. I can't find the
explanation now. I want to share it with my naturopath, so can you please
help me find it? Thank you.
Dr. Lowe:
I apologize, but I can’t
find it on the website either. However, I explained it in great detail in my
book The Metabolic Treatment
of Fibromyalgia. It’s a complicated phenomenon, since it involves
certain genes, the proteins they code for, a specialized part of nervous
system, and the heart muscle. But I’ll give you as short an explanation as
I can, with the understanding that it’s greatly oversimplified.
Let’s consider a female patient. She had Graves’ disease and her
thyroid doctor destroyed her thyroid gland with radioactive iodine. Like
most such patients, despite using T4-replacement, she’s since gained a
troubling amount of weight. She’s gained it despite a diet that’s
wholesome and fairly low in calories.
She’s trying to stop or reverse her weight gain with aerobic exercise.
Before developing Graves’, exercise was easy for her. But now she can’t
exercise intensely enough to reduce her weight. Her doctor orders a heart
stress test, and it shows that her heart just doesn’t beat fast and hard
enough, no matter how much effort she exerts.
Her trouble is that the T4-replacement is ineffective for her, just as it isn't
for many other patients. As a result, thyroid hormone is under-regulating a
certain set of her genes, called the "adrenergic genes." A
physiological effect of the under-regulation is that her heart has a
"blunted" response to vigorous exercise. By blunted, I mean that
her heart doesn’t respond vigorously enough to the exercise-induced rise
in her body of two stress hormones, adrenaline and noradrenaline; the
hormones fail to make her heart muscle contract as fast and hard as it does
in people who have normal thyroid hormone regulation.
Because her heart’s response to the stress hormones is blunted, the
heart pumps too little blood into her general circulation. The resulting
less-than-adequate flow of blood to her exercising muscles leaves them
deficient of oxygen. And the oxygen deficit renders the muscles unable of
accommodating her desire to exercise hard enough to lose weight.
Inadequate thyroid hormone regulation of her adrenergic genes is causing
her blunted heart response through two molecular changes on her cell
membranes. One is a reduced number of excitatory proteins called
"beta-adrenergic receptors"; the other is an increased number of
inhibitory proteins called "alpha2-adrenergic receptors."
Exercising vigorously raises her levels of the two stress hormones, but
because of her receptor imbalance, the hormones don’t have the same effect
they do in someone with normal thyroid hormone regulation of the adrenergic
genes. In the normal person, the hormones bind to more excitatory proteins
and fewer inhibitory ones. This increases his heart’s force and rate of
contraction.
But our patient has too few excitatory proteins and too many inhibitory
ones. So when the stress hormones bind to the proteins, her heart’s force
and rate of contraction fail to increase normally. No matter how hard she
tries, her heart won’t pump enough blood; it can’t, since inadequate
thyroid hormone regulation is holding a molecular brake down on it.
For her, as for many hypothyroid patients, there’s only one way to
recover a normal heart response to exercise: switch from T4-replacement to
either a T4/T3 combination or T3 alone. For an optimal therapeutic effect,
she, like many hypothyroid patients, may have to find a slightly
TSH-suppressive dose that’s not overstimulating.
I hope this makes sense to you and your naturopathic physician and that
you find it of some use in your treatment.
|
If your doctor won't order thyroid antibody lab
tests for you, order the tests yourself. In fact, order
any
lab test you want at discounted fees through our arrangement
with Direct Labs. |
|

Our Educational
Consulting Service
We provide educational consulting to both patients and clinicians.
Phone us at 603-391-6061, or preferably, write to us at
Tammy@drlowe.com. Our fax number
is
303-496-6200. —Tammy Lowe
|
Continued at top of right column
. . .
© 2011 Dr. John C.
Lowe, LLC. All rights reserved. This email newsletter may be copied and
distributed subject to three conditions: (1) All text within the full
document or any section copied must be copied without modification with
all pages included. (2) All copies must contain the following copyright
notice: "© 2011 John C. Lowe." (3) The copy of the newsletter text must
clearly show the original source of publication as "www.drlowe.com." (4)
Neither this full document nor any section of it may be published or
distributed for profit. (5) Except for personal use, the photos cannot be copied, as they are the
intellectual property of individual photographers and made available
through agreement with PhotoXpress. |
Q&As
May 23, 2004

Question:
I am a huge fan of your thyroid research. It’s
because of your research that my doctor put me on Cytomel, which has changed
my life. At age 17, I was diagnosed with thyroid cancer. My thyroid gland
was removed and then I had radiation treatment.
I was then immediately put on Synthroid. The doctor changed my dose once
every couple of months, up and down. But I never felt better and began to
get sicker and sicker. I was 22 and had just graduated college, and I couldn’t
get out of bed in the morning. I’d gained 10-to-20 pounds a year since the
surgery, so I was very overweight. I had joint pain, brain fog, cold
extremities, low body temp, and the list goes on and on. I saw many doctors
who told me nothing was wrong because my TSH was normal.
Then I got fed up and did research of my own. I found a doctor nearby who
prescribes T3 for his fibromyalgia patients. I’m now taking 100 mcg per
day and feel great. I’ve lost 30 pounds and all my other symptoms have
faded away. It’s been wonderful to have a local doctor who responds to
your research. But now he’s concerned because my heart rate is a little
elevated, and he wants to lower my dose. I have no other symptoms of
overdose and great blood pressure. Should I be concerned? I was on 75 mg
before. At that dose, I had some fatigue and didn’t feel nearly as good.
What do you think?
Dr. Lowe:
Congratulations on your
remarkable improvement! I'm happy to hear that our research led to you
getting effective treatment for your fibromyalgia symptoms. We’ve heard
from hundreds of patients such as you who’ve freed themselves from
fibromyalgia symptoms by switching from Synthroid or other brands of T4 to
T3; I’m pleased you’re among them.
If you went from 75 to 100 mcg of T3 in one dosage increase, you may have
overshot slightly; your safe and effective dose may be somewhere between
those two doses. If your doctor decreases your dose, I suggest that he do so
only by a small amount, say 10 mcg, to see if that will slow your heart rate
enough. His aim should be to lower your dose enough to slow your heart rate,
but not so much that your fibromyalgia symptoms return.
You didn’t say whether you’re doing regular aerobic exercise. If you’re
not, your rapid heart rate may not be from too much T3. Instead, the
mechanism may be a weak heart from deconditioning.
A deconditioned heart contracts more weakly than a well-exercised one. If
the weak heart contractions pump too little blood into the circulation, the
heart will compensate by contracting faster. The faster contractions will
keep enough blood entering the circulation so that sufficient oxygen reaches
the tissues. When the weak heart is driven by T3, it will contract even
faster. It may contract so rapidly that it alarms the patient’s doctor.
The solution to this problem is for the patient to do regular aerobic
exercise to strengthen her heart muscle. With stronger contractions, her
heart rate will decrease, possibly without her lowering her dose of T3.
Of course, if you’re already doing regular aerobic exercise, your
doctor will most likely have to lower your dose of T3. Again, he should find
a dose that slows your heart rate enough but still keeps you free from
fibromyalgia and other hypothyroid symptoms. Please give him my best wishes
for having rescued you from T4-replacement therapy.
June 28, 2001

Question: I am a physician and I
treat hypothyroid patients. Partly because of your writings, some of my
patients want more thyroid hormone than ordinary
replacement doses. Over the past year, I've
found that the higher doses usually work better. I am very concerned,
however, about one thing. Many of these patients are middle-aged,
deconditioned, and I assume that they have some degree of coronary artery
disease. My worry is that the higher doses may cause
myocardial ischemia in
the patients. In your experience, is this a concern with middle-aged
patients?
Dr. Lowe: As I emphasized in
The Metabolic Treatment of
Fibromyalgia,[1]
all doctors who treat patients with thyroid hormone
should cautiously protect the patients from adverse effects on the heart.
The only accurate way to assess the effect of thyroid hormone on a patient’s
heart is to directly monitor cardiac status. At minimum, monitoring
should involve the doctor’s attention to any symptoms the patient may have
that suggest cardiac over-stimulation and EKGs. If the doctor is in doubt, he
should refer the patient for evaluation by a cardiologist.
I want to emphasize that the TSH test has nothing whatever to do with
guarding a patient’s cardiac safety. To infer that a patient has cardiac
over-stimulation because the TSH level is low is scientifically unjustified and
logically unsound. It is ludicrous for a doctor to make this inference when
he can easily and directly monitor how the patient’s heart is responding.
Let me emphasize another important point: Some conventional
endocrinologists have grossly exaggerated the cardiac risks of
TSH-suppressive doses of thyroid hormone. When compared to replacement doses
of thyroid hormone, TSH-suppressive doses are not associated with an
increased incidence of ischemic heart disease. In fact, TSH-suppressive
doses of thyroid hormone protect the heart. TSH-suppressive dosages lower
the levels of blood fats more than replacement doses do. And higher-end
doses of thyroid hormone can halt the progression of coronary artery
disease. In patients who don’t have coronary artery disease,
myocardial ischemia and/or
infarction are rare even in those who are
thyrotoxic.
Moreover, restricting many patients to replacement doses predisposes them
to cardiovascular disease and premature death. With these patients, erring
on the side of safety means one thing—allowing them to use higher-end
rather than lower-end doses of thyroid hormone.
In most patients, then, TSH-suppressive doses of thyroid hormone don’t
harm the heart. This justifies Dr. L.E. Shapiro writing in 1997, "In the absence
of symptoms of thyrotoxicosis, patients treated with TSH-suppressive doses
of L-T4 may be followed clinically without specific cardiac
laboratory studies."[2]
Dr. Gordon Skinner recently wrote that patients with normal thyroid test results who
have symptoms and signs of hypothyroidism should be permitted undergo a
trial of thyroid hormone therapy. Anticipating objections, Skinner wrote,
"The dangers of osteoporosis and cardiac catastrophe—particularly
during a three-month trial—are sometimes quoted, but these worries are
unfounded and condemn many patients to years of hypothyroidism with its
pathological complications and poor quality of life."[3]
A correct
interpretation of the available scientific evidence compels one to agree
with Dr. Skinner.
As I said, some conventional endocrinologists have grossly exaggerated
the cardiac risks of TSH-suppressive doses of thyroid hormone. When doctors
exercise reasonable precaution with their patients, they can safely ignore
these endocrinologists’ exaggerations.
References

[1] Lowe, J.C.: The Metabolic Treatment of
Fibromyalgia. Boulder, McDowell Publishing Co., 2000.

[2] Shapiro, L.E., Sievert, R., Ong, L., et al.: Minimal cardiac effects in
asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive
doses of L-thyroxine. J. Clin Endocrinol. Metab., 82(8):2592-2595,
1997.

[3] Skinner, G.R.B., Thomas, R., Taylor, M.,
et al.: Thyroxine should be tried in clinically hypothyroid but
biochemically euthyroid patients (Letter). Brit. Med. J., 314:1764,
1997.
February 25, 2001

Question: I am a physician in
the United Kingdom who has been using T3 as part of your treatment protocol.
I am presenting a paper at our medical journal club about my practice based
on your book The Metabolic
Treatment of Fibromyalgia. I am doing so because I’ve put some
patients on T3 and feel that my partners should know all about it.
I recently treated a patient with T3 who lives in another city. When her
local GP ran thyroid function tests, he was horrified at the free T3 level.
He referred the patient to her local endocrinologist. The endocrinologist
apparently didn’t agree himself with the treatment, but he referred the
patient to one his colleagues who is interested. The only problem this
patient has is a slightly labile pulse. When she gets stressed or anxious,
her pulse goes up to 120 beats per minute. Otherwise, her resting pulse rate
is 74. This isn’t the only patient of mine who feels better on high
dosages of T3 but experiences episodes of a high pulse rate. Because your
protocol isn’t mainstream medicine and it’s all new to me, I do feel
slightly anxious in case I should run into problems with any patient. This
would lead to complaints. But I am pretty convinced about your protocol. I
have suggested that these patients with episodic high pulse rates reduce
their T3 dosages slightly. Is there anything else you would suggest?
Dr. Lowe: I appreciate both your concern
for patient safety and the need to avoid complaints. Those of us with the
Fibromyalgia Research Foundation are committed to the Hippocratic principle
of doing no harm. The safety of our patients is our foremost concern. In
addition, we’re fully aware of how "the system" works: If we
made a mistake that harmed a patient under our care, some of our
politically-motivated detractors wouldn’t view it as an isolated mishap.
Instead, they’d unjustly use it to try and discredit our entire line of
research. Hence, for more than one reason, patient safety is supremely
important to us.
To avoid adverse effects on patients’ hearts, we insist that
they do everything known to confer cardiovascular health. Specifically, we
insist that each of our patients do at least four things:
!First, the patient must engage in
cardiovascular exercise to tolerance. Tolerance increases as the patient’s
metabolic health improves, and she is then able to increase both her
intensity of exercise and the fitness of her heart.
! Second, unless her diet is already
one that favors cardiovascular health, she must modify it so that it does. A
diet that favors cardiovascular health, for example, includes substantial
daily amounts of vegetables, fruits, and grains, and it includes low amounts
of red meat and sugar-laden and fatty foods.
! Third, the patient must take a full
array of heart-protective nutrients. We provide online the list of
nutritional supplements we insist our patients take. These supplements
include nutrients that take part in protecting the heart against disease and
adverse cardiac events. The supplements we recommend make up our own
nutritional supplement regimen. We based this supplement list largely on the
beliefs of Prof. Linus Pauling.
! Fourth, the patient must take
sufficient time for rest and relaxation. These are intended to reduce the
overall stresses the patient’s cardiovascular system is subjected to.
Let me emphasize that we insist that our patients use these
heart-protective methods. We are as collaborative in our relationships with
patients as any clinicians can be. However, using these methods is not
optional for our patients. Their safety is more important to us than the
principle of collaboration. In fact, I’ve ended my clinical relationships
with a few patients who carried on with large dosages of T3 while declining
to use these heart-protective methods. I considered these patients and the
physicians who continued their T3 prescriptions foolhardy. Fortunately, most
of our patients have been fully cooperative and safety minded. From
experiences with these latter patients, I’m convinced that their use of
these protective methods is responsible for none having had adverse cardiac
effects.
Endocrinology
Specialty's Exaggerated Warnings
of Atrial Fibrillation from TSH-Suppressive Doses of Thyroid Hormone
|